Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.071 | 0.7 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |